Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLSA | AZN | AMGN | GILD | VRTX |
| Company | Tiziana Life Sciences Ltd | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.3100 | 70.40 | 281.12 | 105.68 | 494.26 |
| High | 1.3100 | 72.06 | 289.53 | 107.17 | 505.43 |
| Low | 1.2412 | 69.71 | 279.06 | 104.63 | 490.85 |
| Last | 1.2412 | 71.87 | 289.40 | 106.33 | 505.53 |
| Change | -0.0688 | +1.94 | +6.31 | -0.01 | +9.04 |
| % Change | -5.25% | +2.77% | +2.23% | -0.01% | +1.82% |
| Volume | 91,306 | 5,548,300 | 973,273 | 2,849,412 | 563,449 |
| 20-Day Average Volume | 330,729 | 7,045,032 | 3,131,185 | 9,616,311 | 1,639,927 |
| Previous Close | 1.3100 | 69.93 | 283.09 | 106.34 | 496.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0397 | 68.52 | 287.81 | 106.08 | 486.72 |
| 20-Day Raw Stochastic | 64.67% | 73.24% | 43.42% | 60.23% | 98.27% |
| 20-Day Relative Strength | 55.19% | 53.42% | 46.97% | 49.57% | 57.49% |
| Weighted Alpha | -5.43 | -5.82 | -8.34 | +59.08 | +23.21 |
| Today's Opinion | 72% Buy | 24% Sell | 56% Sell | 56% Buy | 64% Buy |
| Previous Opinion | 72% Buy | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 64% Buy | 24% Buy | 32% Buy | 80% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.53% since 04/22/25 | +5.83% since 04/22/25 | +3.46% since 04/22/25 | +0.70% since 04/22/25 | +2.76% since 04/22/25 |
| Low | 1.1400 on 04/23/25 | 68.36 on 04/23/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 484.50 on 04/25/25 |
| High | 1.5300 on 04/24/25 | 71.91 on 04/29/25 | 288.64 on 04/29/25 | 107.56 on 04/24/25 | 504.99 on 04/29/25 |
| 1-Month | |||||
| %Chg | +11.37% since 03/28/25 | -2.66% since 03/28/25 | -6.17% since 03/28/25 | -4.96% since 03/28/25 | +2.30% since 03/28/25 |
| Low | 0.7301 on 04/11/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 1.5300 on 04/24/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 504.99 on 04/29/25 |
| 3-Month | |||||
| %Chg | +80.26% since 01/29/25 | +2.25% since 01/29/25 | +2.25% since 01/29/25 | +11.15% since 01/29/25 | +14.15% since 01/29/25 |
| Low | 0.6302 on 02/06/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 435.00 on 01/30/25 |
| High | 1.9100 on 03/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +22.29% since 10/29/24 | -4.51% since 10/29/24 | -8.85% since 10/29/24 | +20.63% since 10/29/24 | +7.15% since 10/29/24 |
| Low | 0.6295 on 12/31/24 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 1.9100 on 03/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 153,071 | 216,870,208 | 152,203,616 | 132,410,632 | 127,638,144 |
| Shares Outstanding, K | 116,848 | 3,101,247 | 537,651 | 1,245,163 | 257,081 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -17,690,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | N/A | 14,891,000,000 | 9,086,000,000 | 6,667,000,000 | 2,912,000,000 |
| Last Quarter Net Income | N/A | 1,499,000,000 | 627,000,000 | 1,315,000,000 | 913,000,000 |
| 60-Month Beta | 0.54 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/09/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |